Effects	effects	O	O	O	O
of	of	O	O	O	O
pallidal	pallidal	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
haloperidol-induced	haloperidol-induced	O	O	O	O
parkinsonian	parkinsonian	O	DISEASE	OTHERS	I
catalepsy	catalepsy	O	DISEASE	OTHERS	I
:	:	O	O	O	O
behavioral	behavioral	O	O	O	O
and	and	O	O	O	O
electrophysiological	electrophysiological	O	O	O	O
studies	studies	O	O	O	O
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
globus	globus	O	O	O	O
pallidus	pallidus	O	O	O	O
plays	plays	O	O	O	O
a	a	O	O	O	O
critical	critical	O	O	O	O
role	role	O	O	O	O
in	in	O	O	O	O
movement	movement	O	O	O	O
regulation	regulation	O	O	O	O
.	.	O	O	O	O

Previous	previous	O	O	O	O
studies	studies	O	O	O	O
have	have	O	O	O	O
indicated	indicated	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
globus	globus	O	O	O	O
pallidus	pallidus	O	O	O	O
receives	receives	O	O	O	O
neurotensinergic	neurotensinergic	O	O	O	O
innervation	innervation	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
striatum	striatum	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
systemic	systemic	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
analog	analog	O	O	O	O
could	could	O	O	O	O
produce	produce	O	O	O	O
antiparkinsonian	antiparkinsonian	O	O	O	O
effects	effects	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
aimed	aimed	O	O	O	O
to	to	O	O	O	O
investigate	investigate	O	O	O	O
the	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
pallidal	pallidal	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
haloperidol-induced	haloperidol-induced	O	O	O	O
parkinsonian	parkinsonian	O	DISEASE	OTHERS	I
symptoms	symptoms	O	O	OTHERS	I
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
Behavioral	behavioral	O	O	O	O
experiments	experiments	O	O	O	O
and	and	O	O	O	O
electrophysiological	electrophysiological	O	O	O	O
recordings	recordings	O	O	O	O
were	were	O	O	O	O
performed	performed	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Bilateral	bilateral	O	O	O	O
infusions	infusions	O	O	O	O
of	of	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
into	into	O	O	O	O
the	the	O	O	O	O
globus	globus	O	O	O	O
pallidus	pallidus	O	O	O	O
reversed	reversed	O	O	O	O
haloperidol-induced	haloperidol-induced	O	O	O	O
parkinsonian	parkinsonian	O	DISEASE	OTHERS	I
catalepsy	catalepsy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Electrophysiological	electrophysiological	O	O	O	O
recordings	recordings	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
microinjection	microinjection	O	O	O	O
of	of	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
excitation	excitation	O	O	O	O
of	of	O	O	O	O
pallidal	pallidal	O	O	O	O
neurons	neurons	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
systemic	systemic	O	O	O	O
haloperidol	haloperidol	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
type-1	type-1	O	O	OTHERS	I
receptor	receptor	O	O	OTHERS	I
antagonist	antagonist	O	O	OTHERS	I
SR48692	sr48692	O	O	OTHERS	I
blocked	blocked	O	O	O	O
both	both	O	O	O	O
the	the	O	O	O	O
behavioral	behavioral	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
electrophysiological	electrophysiological	O	O	O	O
effects	effects	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
Activation	activation	O	O	O	O
of	of	O	O	O	O
pallidal	pallidal	O	O	O	O
neurotensin	neurotensin	CHEMICALS	O	OTHERS	I
receptors	receptors	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
neurotensin-induced	neurotensin-induced	O	O	O	O
antiparkinsonian	antiparkinsonian	O	O	O	O
effects	effects	O	O	O	O
.	.	O	O	O	O

